Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» New competition took a bite out of J&J’s drug sales, but don’t expect the trend to dominate this earnings season
New competition took a bite out of J&J’s drug sales, but don’t expect the trend to dominate this earnings season
New competition took a bite out of J&J’s drug sales, but don’t expect the trend to dominate this earnings season
Submitted by
admin
on January 29, 2017 - 11:57am
Source:
Marketwatch
News Tags:
JNJ
earnings
Remicade
biosimilars
Headline:
New competition took a bite out of J&J’s drug sales, but don’t expect the trend to dominate this earnings season
Do Not Allow Advertisers to Use My Personal information
